Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease

Author:

Virameteekul Sasivimol123ORCID,Lees Andrew J.2ORCID,Bhidayasiri Roongroj34ORCID

Affiliation:

1. Department of Biochemistry, Faculty of Medicine Chulalongkorn University Bangkok Thailand

2. Reta Lila Weston Institute of Neurological Studies UCL Queen Square Institute of Neurology London UK

3. Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society Bangkok Thailand

4. The Academy of Science, The Royal Society of Thailand Bangkok Thailand

Abstract

AbstractDespite the availability of a number of efficacious treatments for Parkinson's disease, their limitations and drawbacks, particularly related to low brain bioavailability and associated side effects, emphasize the need for alternative and more effective therapeutic approaches. Nanomedicine, the application of nanotechnology in medicine, has received considerable interest in recent years as a method of effectively delivering potentially therapeutic molecules to the brain. In particular, polymeric nanoparticles, constructed from biodegradable polymer, have shown great promise in enhancing therapeutic efficacy, reducing toxicity, and ensuring targeted delivery. However, their clinical translation remains a considerable challenge. This article reviews recent in vitro and in vivo studies using polymeric nanoparticles as drug and gene delivery systems for Parkinson's disease with their challenges and future directions. We are also particularly interested in the technical properties, mechanism, drugs release patterns, and delivery strategies to overcome the blood–brain barrier. © 2024 International Parkinson and Movement Disorder Society.

Publisher

Wiley

Reference143 articles.

1. Parkinson's disease: clinical features and diagnosis;Jankovic J;J Neurol Neurosurg Psychiatry,2008

2. Parkinson's disease: mechanisms and models;Dauer W;Neuron,2003

3. Pharmacokinetics of levodopa;Contin M;J Neurol,2010

4. Pharmacokinetic optimisation in the treatment of Parkinson's disease;Contin M;Clin Pharmacokinet,1996

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3